Amitriptyline is used to treat depression by increasing amounts of certain natural chemicals in the brain needed for mental balance. It belongs to a class of older antidepressants and may also be used for nerve pain, eating disorders, and migraine prevention.[2] Elavil is currently approved and in use across 25 indications[4].[1]
Elavil is one of 433 small molecule programs targeting Intervertebral Disc Displacement. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
102 competitors in Migraine
Elavil
Avicel
Effient
Magnesium
Triptans
Aspirin /d
Flunarizine
Bayer Aspirin
Cervidil
Adempas
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
ELAVIL
NDA NDA012704
Jan 1, 1982
ELAVIL
NDA NDA012703
Sources
Details